• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于制备物理稳定纳米混悬液的不同表面修饰剂的系统筛选

Systematic Screening of Different Surface Modifiers for the Production of Physically Stable Nanosuspensions.

作者信息

Lestari Maria L A D, Müller Rainer H, Möschwitzer Jan P

机构信息

Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Freie Universität Berlin, Berlin, Germany; Department of Pharmaceutics, Universitas Airlangga, Surabaya, Indonesia.

Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Freie Universität Berlin, Berlin, Germany.

出版信息

J Pharm Sci. 2015 Mar;104(3):1128-1140. doi: 10.1002/jps.24266. Epub 2016 Jan 8.

DOI:10.1002/jps.24266
PMID:28756835
Abstract

The role of a surface modifier is important in the formation of stable nanosuspensions. In this study, a simple and systematic screening method for selecting optimum surface modifiers was performed by utilizing a low-energy wet ball milling method. Nine surface modifiers from different classes with different stabilization mechanisms were applied on six different models of active pharmaceutical ingredients (API). Particle size analysis showed that at concentration five times higher than the critical micelle concentration, SDS and sodium cholate (anionic surfactant) showed the highest percent success to produce stable nanosuspensions with particle size smaller than 250nm. Similar findings were also shown by poloxamer 188 (nonionic surfactant) and hydroxypropylmethylcellulose E5 (polymeric stabilizer) at concentration 1% (w/v) and 0.8% (w/v), respectively. In addition, combinations of anionic surfactant and nonionic surfactant as well as combinations of anionic surfactant and polymeric stabilizer showed high percent success in the formation of stable nanosuspensions. In general, no correlation can be found between the physicochemical characteristics of the model API (molecular weight, melting point, log P, pKa, and crystallinity) with its feasibility to be nanosized. The concentration and the principle of stabilization of surface modifier determine the formation of stable nanosuspensions. © 2015 Wiley Periodicals, Inc. and the American Pharmacists Association.

摘要

表面改性剂在稳定纳米混悬液的形成过程中起着重要作用。在本研究中,通过使用低能湿球磨法,执行了一种简单且系统的筛选方法来选择最佳表面改性剂。将九种来自不同类别、具有不同稳定机制的表面改性剂应用于六种不同的活性药物成分(API)模型。粒度分析表明,在浓度高于临界胶束浓度五倍时,十二烷基硫酸钠(SDS)和胆酸钠(阴离子表面活性剂)在制备粒径小于250nm的稳定纳米混悬液方面成功率最高。泊洛沙姆188(非离子表面活性剂)和羟丙基甲基纤维素E5(聚合物稳定剂)在浓度分别为1%(w/v)和0.8%(w/v)时也显示出类似的结果。此外,阴离子表面活性剂与非离子表面活性剂的组合以及阴离子表面活性剂与聚合物稳定剂的组合在形成稳定纳米混悬液方面成功率很高。一般来说,模型API的物理化学特性(分子量、熔点、log P、pKa和结晶度)与其纳米化的可行性之间没有相关性。表面改性剂的浓度和稳定原理决定了稳定纳米混悬液的形成。© 2015威利期刊公司和美国药剂师协会。

相似文献

1
Systematic Screening of Different Surface Modifiers for the Production of Physically Stable Nanosuspensions.用于制备物理稳定纳米混悬液的不同表面修饰剂的系统筛选
J Pharm Sci. 2015 Mar;104(3):1128-1140. doi: 10.1002/jps.24266. Epub 2016 Jan 8.
2
Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.对用于制备物理稳定纳米混悬液的不同表面改性剂进行系统筛选。
J Pharm Sci. 2015 Mar;104(3):1128-40. doi: 10.1002/jps.24266. Epub 2015 Jan 28.
3
Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?纤维素聚合物与阴离子表面活性剂的组合是否是确保BCS II类药物纳米混悬液物理稳定性的良好策略?
Pharm Dev Technol. 2016;21(4):499-510. doi: 10.3109/10837450.2015.1022788. Epub 2015 Mar 16.
4
The Scalability of Wet Ball Milling for The Production of Nanosuspensions.用于生产纳米悬浮液的湿式球磨法的可扩展性
Pharm Nanotechnol. 2019;7(2):147-161. doi: 10.2174/2211738507666190401142530.
5
Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.湿磨灰黄霉素纳米混悬剂的多面特性研究,阐明其聚集状态和稳定机制。
AAPS PharmSciTech. 2018 May;19(4):1789-1801. doi: 10.1208/s12249-018-0993-4. Epub 2018 Mar 30.
6
Thermodynamics of aggregate formation between a non-ionic polymer and ionic surfactants: An isothermal titration calorimetric study.非离子聚合物与离子表面活性剂之间聚集体形成的热力学:等温滴定量热研究。
Int J Pharm. 2017 Jan 10;516(1-2):131-143. doi: 10.1016/j.ijpharm.2016.10.053. Epub 2016 Oct 24.
7
A screening study of surface stabilization during the production of drug nanocrystals.药物纳米晶体生产过程中表面稳定化的筛选研究。
J Pharm Sci. 2009 Jun;98(6):2091-103. doi: 10.1002/jps.21563.
8
Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.采用高压匀质法制备纳米混悬剂提高普仑司特的溶出度和口服生物利用度。
Drug Dev Ind Pharm. 2012 Nov;38(11):1381-9. doi: 10.3109/03639045.2011.652636. Epub 2012 Feb 3.
9
Resveratrol nanosuspensions for dermal application--production, characterization, and physical stability.用于皮肤应用的白藜芦醇纳米混悬剂——制备、表征及物理稳定性
Pharmazie. 2009 Nov;64(11):741-7.
10
Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.难溶性药物的纳米混悬剂:湿磨法制备与开发。
Int J Pharm. 2011 Jun 15;411(1-2):215-22. doi: 10.1016/j.ijpharm.2011.03.050. Epub 2011 Mar 31.

引用本文的文献

1
A Systematic Investigation of Process Parameters for Small-Volume Aqueous Suspension Production by the Use of Focused Ultrasonication.采用聚焦超声法生产小体积水混悬液的工艺参数系统研究。
AAPS PharmSciTech. 2024 Aug 13;25(6):185. doi: 10.1208/s12249-024-02907-6.
2
Osmolality of Excipients for Parenteral Formulation Measured by Freezing Point Depression and Vapor Pressure - A Comparative Analysis.辅料的等渗性通过冰点降低和蒸气压测量——比较分析。
Pharm Res. 2023 Jul;40(7):1709-1722. doi: 10.1007/s11095-022-03262-6. Epub 2022 Apr 22.
3
Progress and Principle of Drug Nanocrystals for Tumor Targeted Delivery.
药物纳米晶用于肿瘤靶向递药的进展与原理。
AAPS PharmSciTech. 2021 Dec 28;23(1):41. doi: 10.1208/s12249-021-02200-w.
4
Temperature-Induced Surface Effects on Drug Nanosuspensions.温度诱导的药物纳米混悬剂表面效应。
Pharm Res. 2018 Feb 21;35(3):69. doi: 10.1007/s11095-017-2300-6.